 |
- Paris - France
- cGMP production of advanced intermediates & APIs
- 122 employees
- Last FDA-inspection in 2007
- Inspected by Japanese KIKO in 2007
- 65 m3 of reactors over two workshops
- Workshop Pharma I dedicated
- Workshop Pharma II multipurpose 30 m3 (800-2,500 L)
- Process development resources shared with PCAS Limay
- Pilot plant
|
Differentiating technologies
- Wide range of chemistry (Temp. -20°C to +150°C)
- Capabilities to handle isolation, drying and milling of injectable APIs (Class 10,000)
Special equipment: Small-scale multi-purpose equipment for the manufacture of high-value APIs, production of specific antibiotics
